Info

4 yr DFS 52.2% 42.2% p = 0.044

30.4% 52.5% p < 0.001

4 yr OS Favorable: 68.1 vs 73.9% Intermediate: 53.4 vs 54.3%

Unknown cytogenetics unknown in ~40% Only 56% of AutoSCT group and 69% of AlloSCT group underwent transplant after achieving CR Age was predictor of disease-free outcome at 4 years:

Adverse (pooled) Age 15-25: 64.0 vs 50.8%, Hazard : 0.65 50.2 vs 29.4% (0.41-1.04),

26-35: 61.9 vs 49.6% 0.69 (0.46-1.02) 36-45: 53.4 vs 51.6% 0.97 (0.7-1.33) Cox model suggests: Worse prognosis associated with most gain from AlloSCT

Hellenic Cooperative

Age <50

AlloSCT vs

0 0

Post a comment